Literature DB >> 7912683

Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer.

A W Menzin, S A King, J K Aikins, J J Mikuta, S C Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7912683

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

Review 1.  Mechanisms of cancer cell death induction by paclitaxel: an updated review.

Authors:  Shuang Zhao; Yufei Tang; Ruohan Wang; Masoud Najafi
Journal:  Apoptosis       Date:  2022-07-18       Impact factor: 5.561

Review 2.  Mechanisms of Chemotherapy-Induced Neurotoxicity.

Authors:  Halina Was; Agata Borkowska; Ana Bagues; Longlong Tu; Julia Y H Liu; Zengbing Lu; John A Rudd; Kulmira Nurgali; Raquel Abalo
Journal:  Front Pharmacol       Date:  2022-03-28       Impact factor: 5.810

3.  Novel adult cortical neuron processing and screening method illustrates sex- and age-dependent effects of pharmaceutical compounds.

Authors:  Arthur Sefiani; Ivan Rusyn; Cédric G Geoffroy
Journal:  Sci Rep       Date:  2022-07-30       Impact factor: 4.996

Review 4.  Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy.

Authors:  Jan Škubník; Vladimíra Pavlíčková; Tomáš Ruml; Silvie Rimpelová
Journal:  Plants (Basel)       Date:  2021-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.